Product Program year 2025 Source: CMS Open Payments

RhodoLED XL

Device Dermatology

PDI 04260308240164

Open in the dashboard

General payments

$198,095

2,734 payments

Research payments

$1,301,425

162 payments

Through program year 2025, $198,095 in general payments and $1,301,425 in research payments were reported against RhodoLED XL (Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $73,219 154
2025 Research $1,073,320 139
2024 General $124,876 2,580
2024 Research $228,105 23

Breakdown

Who paid General payments · program years 2024–2025
  1. Biofrontera Inc. $198,095 2,734 payments
Top recipients General payments · program year 2025
  1. Armand Cognetta MOHS-Micrographic Surgery · Tallahassee, FL $14,909 20% · 1 payment
  2. Cleveland Clinic Hospital Teaching hospital · OH $13,761 19% · 1 payment
  3. Ashish Bhatia Procedural Dermatology · Itasca, IL $13,699 19% · 1 payment
  4. Joel Cohen MOHS-Micrographic Surgery · Greenwood Village, CO $13,687 19% · 1 payment
  5. Brad Glick Dermatology · Margate, FL $13,561 19% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. MOHS-Micrographic Surgery Dermatology $28,814 49% · 11 practitioners
  2. Dermatology $15,592 26% · 83 practitioners
  3. Procedural Dermatology Dermatology $13,772 23% · 4 practitioners
  4. Physician Assistant $725 1% · 30 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $218 <1% · 9 practitioners

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $29,172 40% · 31 recipients
  2. Ohio $13,785 19% · 2 recipients
  3. Illinois $13,772 19% · 4 recipients
  4. Colorado $13,687 19% · 1 recipient
  5. California $556 <1% · 23 recipients

The top 5 of 27 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,734 general · 162 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record